Cancer Monoclonal Antibodies Market to reach USD 45 Billion by 2020

According to the report "Caner Monoclonal Antibodies Market", published by Market Data Forecast, the global market is projected to reach USD 45 Billion by 2020, at a CAGR of 11.2% from 2015 to 2020.

For full report refer to: http://www.marketdataforecast.com/market-reports/global-cancer-monoclonal-antibodies-market-185/

Monoclonal Antibodies (mAbs) are mono-specific antibodies bodies comprising of identical immune cells that are clones of a single parent cells and are directed to a specific cellular targets. Thus Monoclonal Antibodies are highly customizable due to its specific nature and can play a crucial role in eliminating the cancerous cell while sparing the normal cells during the cancer treatment. The monoclonal antibodies are proved to be more effective than chemotherapies and drugs for cancer treatment due to its specificity.

Free sample for the report is available at: http://www.marketdataforecast.com/market-reports/global-cancer-monoclonal-antibodies-market-185/request-sample

The dramatic increase in the cancer cases has led many pharmaceutical companies to invest in monoclonal antibodies market. Increasing investment in research and development of genomic studies, technological advancements in genetic sequencing and target gene selection, specificity of monoclonal antibodies to target only the cancer cells with no side effects are the driving forces of the market. With the increased prevalence of cancer, it is expected to grow lucratively in the next 5 years with the presence of strong products in the pipeline.

Global Monoclonal Antibodies Market is segmented on the basis of application, type and Conjugated Cancer therapies.
By Application
• Liver
• Breast
• Brain
• Blood
• Hodgkins and Non-Hodgkins lymphoma
• Colorectal
• Leukaemia
• And others
By Type
• Murine Antibodies
• Chimeric and Humanised Antibodies
• Fully Humanized Antibodies
Conjugated Cancer Therapies
• Immunoliposome
• Radioimmunotherapy
• ADEPT
• Immunocytokines
• And others
On the basis of Geography
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle-East & Africa

The highly customizable nature of the monoclonal antibodies are attracting various organizations, research institutes and multinational companies to use it as a tool to cure cancer. The major players in the Cancer Monoclonal Antibodies Market are Amgen, Genmab, Glaxosmithkline, Bristol Meyer Squibb, Roche, Eli Lilly, Immunogen, Novartis, Seattle Genetics and Spectrum Pharmaceuticals.

About Market Data Forecast:
Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organisation that’s trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.

Contact:
Market Data Forecast, Inc.,
Jubilee Gardens,
Hyderabad, India.
+1-888-702-9626 (U.S. TOLL FREE)
Email: contact@marketdataforecast.com

This release was published on openPR.